经改良中长导管输注20%甘露醇溶液的效果评价
|
摘要
目的探究经改良中长导管是否可以安全输注20%甘露醇溶液。方法将需进行20%甘露醇静脉输液治疗的神经内科60例脑卒中患者分为两组,试验组与对照组,每组各30例。对照组通过股静脉输注,试验组通过改良中长导管输注,观察并记录输液期间导管相关并发症及穿刺成本。结果两组患者导管相关并发症发生率比较,试验组中发生1例(3.4%)静脉炎,未发生其他导管相关性并发症;对照组中发生2例(6.7%)可疑导管相关血流感染,两组比较,差异无统计学意义(P> 0.05);试验组穿刺耗时为(25.28±7.36)min,低于对照组的(42.20±10.61)min,差异具有统计学意义(P=0.000);两组耗材成本无差异,均为442元/套。两组患者的导管穿刺次数、留置时间比较,差异无统计学意义(P> 0.05)。结论经改良中长导管进行上肢深静脉输注20%甘露醇是安全的,不会增加导管相关并发症的发生率,有效地避免中心静脉导管相关并发症,且穿刺较中心静脉置管容易,成本较低。
Objective To determine if intravenous 20% mannitol could be safely administered through a modified midline catheter. Methods 60 stroke patients in neurology department who needed 20% mannitol intravenous infusion were divided into two groups, the experimental group and the control group, 30 cases in each group. The control group received femoral vein infusion. The experimental group received modified medium and long catheter infusion, to observe and record catheter-related complications and puncture costs during infusion. Results Comparing the incidence of catheter-related complications between the two groups, 1 case(3.4%) of phlebitis occurred in the experimental group, and no other catheterrelated complications occurred. 2 cases(6.7%) of suspicious catheterrelated bloodstream infections occurred in the control group. There was no significant difference between two groups(P > 0.05). The puncture time of the experimental group was(25.28±7.36) minutes, which was lower than that of the control group(42.20±10.61) minutes, and the difference was statistically significant(P=0.000). There was no difference in the cost of consumables between the two groups, which was 442 yuan per set. There was no significant difference in the number of catheter puncture and indwelling time between the two groups(P > 0.05). ConclusionsIntravenous 20% mannitol can be safely and cost-efficiently through the midline study device in the deep vessels of the upper arm.
Objective To determine if intravenous 20% mannitol could be safely administered through a modified midline catheter. Methods 60 stroke patients in neurology department who needed 20% mannitol intravenous infusion were divided into two groups, the experimental group and the control group, 30 cases in each group. The control group received femoral vein infusion. The experimental group received modified medium and long catheter infusion, to observe and record catheter-related complications and puncture costs during infusion. Results Comparing the incidence of catheter-related complications between the two groups, 1 case(3.4%) of phlebitis occurred in the experimental group, and no other catheterrelated complications occurred. 2 cases(6.7%) of suspicious catheterrelated bloodstream infections occurred in the control group. There was no significant difference between two groups(P > 0.05). The puncture time of the experimental group was(25.28±7.36) minutes, which was lower than that of the control group(42.20±10.61) minutes, and the difference was statistically significant(P=0.000). There was no difference in the cost of consumables between the two groups, which was 442 yuan per set. There was no significant difference in the number of catheter puncture and indwelling time between the two groups(P > 0.05). ConclusionsIntravenous 20% mannitol can be safely and cost-efficiently through the midline study device in the deep vessels of the upper arm.
引文
[1]蒋峰,梁小琴,金爽.不同方法静脉输注甘露醇所致静脉炎发生率的比较[J].中华现代护理杂志,2014,49(18):2287-2288.
[2]李彬,邓丽娜,赵蕾,等.老年住院患者静脉中长导管临床相关并发症调查[J].中国老年保健医学,2018,16(2):130-131.
[3]邹晓春,何金爱,宋燕伶.252例留置静脉中长导管患者调查分析[J].护理学报,2016,23(20):48-50.
[4]胡明明,沈小芳,顾平,等.国外中等长度导管的应用研究及启示[J].护理学报,2015,22(12):33-35.
[5]席丽娜,彭惠,梁红,等.彩超下改良塞丁格技术与中长导管在肿瘤患者中的应用[J].临床医药文献杂志,2016,3(34):6791-6792.
[6]陈小丽,黄文红.清凉膏外敷治疗甘露醇外周静脉输注所致静脉炎43例[J].浙江中医杂志,2014,49(8):585.
[7]李玉佳,刘永芳.完全胃肠外营养致周围静脉炎的护理[J].甘肃医药,2018,37(7):666-667.
[8]尹萍.导管相关感染的研究进展[J].中国疗养医学,2015,3(24):234-235.
[9]盛春梅.彩超对上肢静脉内血栓的临床诊断价值分析[J].中国医药指南,2018,16(25):24.
[10]徐雪飞,吴霞云,柴秀琴,等.创伤行静脉留置导管患者血流感染病原菌分布及相关因素与预后研究[J].中华医院感染学杂志,2018,28(14):2124-2126.
[11]Caparas JV,Hu JP.Safe Administration of Vancomycin through a Novel Midline Catheter:A Randomized,Prospective Clinical Trial[J].J Vasc Access,2014,15(4):251-256.
[12]王欣.B超引导下赛丁格技术置入中长导管在神经内科应用的护理体会[J].当代护士,2016(6):39-40.
[2]李彬,邓丽娜,赵蕾,等.老年住院患者静脉中长导管临床相关并发症调查[J].中国老年保健医学,2018,16(2):130-131.
[3]邹晓春,何金爱,宋燕伶.252例留置静脉中长导管患者调查分析[J].护理学报,2016,23(20):48-50.
[4]胡明明,沈小芳,顾平,等.国外中等长度导管的应用研究及启示[J].护理学报,2015,22(12):33-35.
[5]席丽娜,彭惠,梁红,等.彩超下改良塞丁格技术与中长导管在肿瘤患者中的应用[J].临床医药文献杂志,2016,3(34):6791-6792.
[6]陈小丽,黄文红.清凉膏外敷治疗甘露醇外周静脉输注所致静脉炎43例[J].浙江中医杂志,2014,49(8):585.
[7]李玉佳,刘永芳.完全胃肠外营养致周围静脉炎的护理[J].甘肃医药,2018,37(7):666-667.
[8]尹萍.导管相关感染的研究进展[J].中国疗养医学,2015,3(24):234-235.
[9]盛春梅.彩超对上肢静脉内血栓的临床诊断价值分析[J].中国医药指南,2018,16(25):24.
[10]徐雪飞,吴霞云,柴秀琴,等.创伤行静脉留置导管患者血流感染病原菌分布及相关因素与预后研究[J].中华医院感染学杂志,2018,28(14):2124-2126.
[11]Caparas JV,Hu JP.Safe Administration of Vancomycin through a Novel Midline Catheter:A Randomized,Prospective Clinical Trial[J].J Vasc Access,2014,15(4):251-256.
[12]王欣.B超引导下赛丁格技术置入中长导管在神经内科应用的护理体会[J].当代护士,2016(6):39-40.